PILA: CEO comments new Obesity study agreement with Gubra
-
Clinical stage biotech company PILA PHARMA has entered into an agreement with the Danish research organisation Gubra to conduct preclinical studies of the their drug candidate, a TRPV1 inhibitor called XEN-D0501, in obesity. The studies aim to show proof-of-concept in obesity rat models and constitute an important step in the company's development of this innovative treatment as a potential next generation, oral, first-in-class drug candidate. In an interview with Direkt Studios, CEO Gustav H. Gram comments on the significance of the agreement and the next step in the research program.
Pila Pharma har en betalt digital IR-aftale med Proinvestor.com.
-
PILA PHARMA - En satsning på fedme med ny alternativ tablet behandling
Adm. Direktør Gustav H. Gram giver en introduktion til PILA PHARMA og dets orale lægemiddelskandidat, en TRPV1-hæmmer, som nu positioneres til behandling af fedme.
Optaget til Mød Selskabet / DAF Talks i Fredercia d. 24 September.
-
Biostock: PILA PHARMA indleder samarbejde med Gubra om prækliniske fedmestudier
"Samarbejdet med Gubras prækliniske forskningsenhed er særligt interessant, givet Gubras solide erfaring med at generere data af høj kvalitet. Det har blandt andet muliggjort deres egen bioteknologiske afdelings højprofilerede samarbejde med medicinalgiganten Abbvie om en langtidsvirkende amylinanalog, GUB014295 . Aftalen, der er til en værdi af 2,2 milliarder USD, er en af de største inden for fedme i år og sætter standarden for nye innovative tilgange, som f.eks. den, PILA PHARMA arbejder på."
-
Insiderkøb PILA PHARMA: CEO Gustav H. Gram acquires additional shares
https://www.nordnet.dk/markedet/nyheder/a57b2157-eb58-456b-8bb9-dae790023b55
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind